Fig. 7From: Development and validation of a molecular prognostic index of bladder cancer based on immunogenomic landscape analysisPrognostic evaluation of molecular prognostic index. The distribution of risk score (a). The distribution of survival time (b). The expression Heatmap of this index (c)Back to article page